Myoblast fusion is critical for muscle growth, regeneration, and repair. We previously reported that the enzyme peptidyl-prolyl cis-trans isomerase NIMA interacting 1 (Pin1) is involved in osteoclast fusion. The objective of this study was to investigate the possibility that Pin1 also inhibits myoblast fusion. Here, 
2004). The TGF-β superfamily directly activates the Smad signaling pathway, in addition to other Smad-independent pathways, thus potently, yet reversibly, suppressing myoblast differentiation and fusion (Liu, Black, & Derynck, 2001) . TGF-β and myostatin induce the phosphorylation of receptor-activated Smads (R-Smads), Smad2 and Smad3. As adults advance in age, their muscles begin to produce excessive TGF-β (but not myostatin), which upregulates pSmad3 and reduces the regenerative capacity of the muscle that is mainly mediated by fusion of satellite cells (Carlson, Hsu, & Conboy, 2008) .
Peptidyl-prolyl cis-trans isomerase NIMA interacting 1 (Pin1) is a highly conserved peptidyl-prolyl isomerase (PPI) with high binding specificity. Pin1 catalyzes the isomerization of the peptide bond between a phosphorylated serine or threonine residue and a following proline residue (pSer-Thr-Pro motif) in substrate proteins (Kamato et al., 2013) . Proline residues in molecules assist in the adoption of the cis or trans conformation, often with a wide array of biological consequences, depending on configuration. Pin1 has been implicated in several disease states . The linker region of Smad3 was found to have multiple binding sites for Pin1 , with different consequences depending on cell type (Matsuura et al., 2010; Nakano et al., 2009; Shen et al., 2012) .
In cardiac muscle, the Pin1 protein seems to operate within a limited range, as both upregulation and downregulation of Pin1 attenuate cardiac hypertrophy (Toko et al., 2013) . Apart from a few molecular experiments on osteoclasts (Islam et al., 2014) , no studies have examined the role of this critical regulatory molecule in postmitotic cells in a physiological context. Pin1 was found to be involved in osteoclast fusion (Islam et al., 2014) , a physiological process of syncytia formation similar to myoblast fusion. Considering the central role of proline-directed Ser-Thr kinases in the control of skeletal muscle differentiation, coupled with emerging evidence that the enzymatic activity of Pin1 promotes the regulatory postphosphorylation of proteins at sites of proline-dependent phosphorylation, we evaluated whether Pin1 also modulates myoblast fusion and influences the pathways regulating muscle mass.
| MATERIALS AND METHODS

| Animals and diets
Pin1
+/− mice on a mixed genetic background (Fujimori et al., 1999) were bred to yield Pin1 +/+ , Pin1
, and Pin1 −/− on a C57Bl6 background. Male Pin1 +/− and littermate control Pin1 +/+ mice on a C57Bl6 genetic background were analyzed at 10 weeks of age. All mice were housed in a mouse facility with a 12 hr light-dark cycle in a temperature-controlled room. The animal care and study protocols were approved by the Animal Care Committee of Seoul National University (protocol SNU-120327-6-3).
| Cell culture
C2C12 (acquired from ATCC) myoblasts were grown and differentiated for 2-5 days in a differentiation medium consisting of Dulbecco's modified eagle medium (DMEM) supplemented with 2% fetal bovine serum (FBS) and 1% antibiotics. Cells within passage eight were used for all experimentation.
| Plasmids
Flag-tagged CS2 Smad3-WT, CS2 Smad3 T179V, CS2 Smad3 S204A, CS2
Smad3 S208A, and CS2 Smad3 S213A (Kretzschmar, Doody, Timokhina, & Massague, 1999) were gifts from Joan Massague (Addgene plasmid).
| Cytotoxicity assay
The cell cytotoxicity was measured using the EZ-Cytox cell viability assay kit (Daeillab Service, Seoul, Korea) . Briefly, 100 μl of C2C12 cell suspension (3,000 cells per well) was added to each well of a 96-well plate. After the required incubation with the Pin1 inhibitor in fusogenic media (DMEM with 2% FBS) for 48 hr, 10 μl of the EZ-Cytox solution was added to each well of the plate and incubated at 37°C for 2-4 hr. The absorbance was measured by spectrophotometry at 450 nm.
| Fluorescence microscopy and quantitative analysis of fusion
For the measurement of fusion, myoblasts were plated in growth medium on cover slips inside six-well plates at 1.5 × 10 5 cells per well (C2C12).
Myoblasts were induced to undergo myogenic differentiation as described above. Myoblasts or myotubes were washed and fixed with 4% PFA in phosphate-buffered saline (PBS) for 10 min at room temperature and permeabilized in 0.1% Triton X-100 in PBS for 3 min at room temperature. After being blocked with 2% bovine serum albumin (BSA)-PBS, the cells were stained with the antimyosin antibody (Ab) (Clone MF20, Cat #14-6503-82; Affymetrix Ebioscience, Vienna, Austria) at a 1:100 dilution overnight at 4°C. After being washed with PBS, the cells were incubated with the Cy3-labeled secondary Ab (1:400) for 1 hr at room temperature, stained with 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI, 1 µg/ml; Invitrogen, Carlsbad, CA) for 2 min at room temperature, washed, and mounted with the Vectashield mounting solution. Microscopy was performed using LSM700 and LSM800 (Carl Zeiss, Oberkochen, Germany) confocal laser scanning microscopes and ZEN Blue software for analysis.
For the quantitation of in vitro myoblast fusion, the fusion index was determined as described previously (Islam et al., 2014; Pajcini, Pomerantz, Alkan, Doyonnas, & Blau, 2008; Park et al., 2016; Sun et al., 2010) . Briefly, fluorescent images of six random fields were captured per sample for each experiment, yielding a total of 18 images. ImageJ (National Institutes of Health, Bethesda, Maryland) cell counter plugin software was used to determine the number of nuclei. The fusion index (the percentage of nuclei within myosinpositive cells versus the total number of nuclei) was calculated for each field. Fusion indices from each field for each sample were compiled and are depicted as the mean ± SD. In addition, the number of myosin-positive myotubes per field with 2-4 nuclei (small myotubes) or 5 or more nuclei (large myotubes) was recorded as another means to quantify myoblast fusion. 
| Histology and immunohistochemistry
Muscles were mounted at a resting length, covered in OCT compound, frozen in liquid nitrogen-cooled isopentane, and stored at −80°C until cryosectioning at 7 μm. For immunostaining, muscle sections were fixed in 4% paraformaldehyde (PFA), and epitope retrieval was performed with sodium citrate (10 mM, pH 6.5) at 60°C
for 20 min. Endogenous peroxidase activity was blocked with 3%
hydrogen peroxide in PBS, followed by an additional blocking step with the Mouse-on-Mouse Blocking Reagent (Vector Laboratories, Burlingame, CA). Sections were costained with DAPI (10 nM;
Invitrogen) and mounted with Vectashield fluorescent mounting media. For myonuclear counting, fresh-frozen muscle cross-sections were immunoreacted with dystrophin Ab, followed by Cy3-conjugated secondary Ab or Alexa 488 to delineate the muscle fibers.
Sections were postfixed in 4% paraformaldehyde and then stained with DAPI for visualization of nuclei.
Skeletal muscles or limbs were dissected, and the tissues were fixed in 10% neutral buffered formalin and processed for routine paraffin histology. Frozen and paraffin-embedded sections were cut and stained with haemotoxylin and eosin using routine procedures. Immunohistochemistry was performed by fixation with 1% PFA-PBS; permeabilization with 0.2% Triton X-100 in PBS; blocking with PBS/1% BSA, 1% heatinactivated rabbit serum, and 0.025% Tween 20; incubation with the primary Ab for at least 2 hr; incubation with secondary Alexa-Fluor antibodies (Invitrogen) for 1 hr; and mounting with Vectashield-containing DAPI (°C).
| Subcellular fractionation and western blot analysis
To fractionate C2C12 cells into cytosolic and membrane fractions, 2.9 | Glutathione S-transferase (GST) pull-down assay and coimmunoprecipitation
For the GST pull-down assay, cells were lysed with a single-detergent lysis buffer (50 mm Tris-HCl, pH 8; 150 mm NaCl; 1% Triton X-100)
supplemented with a complete protease inhibitor mixture (Roche Applied Science, Basel, Switzerland) and phosphatase inhibitors (sodium orthovanadate and sodium fluoride). Equal amounts of each protein extract were incubated for 2 hr at 4°C with bacterially purified GST fusion proteins bound to agarose-glutathione beads (Sigma-Aldrich).
After three washings, the 2 × Laemmli loading buffer was added to the beads and proteins were analyzed by Western blot analysis.
| Study design and statistics
Studies were conducted in both blinded and nonblinded fashions. For all studies, the sample sizes are explicitly stated in the figure legends.
Normal distribution was assessed first, and if the data were normally distributed, most differences were analyzed by Student's t test or analysis of variance (using excel or Graphpad Prism software, CA).
The results were considered significant at p < 0.05.
| RESULTS
| Pin1 regulates skeletal muscle fusion
According to previous reports, Pin1 −/− mice exhibit neurodegenerative features in some brain regions in an age-dependent manner but appear relatively normal until they are 3 months old (Fujimori, Takahashi, Uchida, & Uchida, 1999; Liou et al., 2002 Liou et al., , 2003 . We have not found visible differences in muscle bulk among Pin1 Mouse embryonic fibroblasts (MEFs) from Pin1 +/+ and Pin1 +/− mice at passage 3 grow at similar rates, and Pin1 +/− mice have been reported to be similar to normal mice (Fujimori et al., 1999 ).
Muscle biology is intimately related to neurobiology; to avoid confusion, we selected the Pin1 +/− mice as the genetic model with which to analyze the effects of Pin1 on muscle. To identify myonuclei, we used dystrophin staining to label the fiber margins and determined whether each nucleus had its geometric center inside the dystrophin-stained "ring" (Bruusgaard et al., 2012; McCarthy et al., 2011) . In cross-sections of muscle from 10-week-old Pin1 +/− mice, there were more nuclei inside the myofibers when the cell surface area was defined with dystrophin immunostaining (Figure 1a ).
The ratio of myonuclei to fiber cross-sectional area (CSA) was 1.067 ± 0.00693 myonuclei-fiber CSA in Pin1 +/+ cross-sections and 2.144 ± 0.0848 myonuclei-fiber CSA in Pin1 +/− ( Figure 1b) . As the nuclei in each fiber represent the number of cells that fused to form that muscle fiber, we inferred that loss of Pin1 enhanced the fusion of myoblasts in vivo.
| Loss of Pin1 enhances muscle fusion in vitro
As the identification of myonuclei on cross-sections can sometimes be unreliable, we analyzed muscle fusion in vitro with a more controlled experimental design. The C2C12 embryonic skeletal muscle cell line is a well-defined model for in vitro skeletal muscle differentiation. These cells proliferate as myoblasts at high calfserum concentrations (10-15%). When the cells reach confluence, they can be induced to differentiate if the calf-serum concentration is reduced from 10% to 2% or if the medium is switched to contain 5% horse serum (Yaffe & Saxel, 1977) .
Previously, it was observed that Pin1 undergoes differential subcellular relocalization from the nucleus to the cytoplasm during the early phases of myogenic differentiation (Magli et al., 2010b) .
We differentiated C2C12 cells in the presence of different doses We also examined the expression of differentiation markers.
Myogenin ( Figure S1b ).
These data indicate that the muscle phenotype might be regulated by Pin1 with a certain threshold limit and that Pin1 limits excessive fusion.
| Smad3 level in cells of muscle origin regulated by Pin1
The R-Smad proteins are thought to compose one of the main groups of transcription factors during myoblast differentiation and fusion.
The balance between muscle atrophy and hypertrophy also depends on the preferential recruitment of Smad4 to the myostatin pathway versus the bone morphogenetic protein (BMP) pathway (Sartori et al., 2013) . Previously, we identified Pin1 as a critical molecular switch in the determination of Smad1 fate (Yoon et al., 2015) . Because R- Information Figure S2 ), whereas phosphorylated Smad2 and Smad1 levels did not change significantly. Despite their extensive sequence similarity and functional overlaps, Smad2 and Smad3 play distinct roles in the regulation of certain genes (Petersen et al., 2010) and might be differentially regulated (Brown, Pietenpol, & Moses, 2007) , perhaps even in muscle. Thus, we focused exclusively on Smad3 from this point onward. In cells overexpressing Pin1, the transcriptionally active tail-phosphorylated Smad3 was more highly detected inside nuclei than the cytoplasm (Figure 3b ).
To determine whether the degradation of Smad3 in cells treated with the Pin1 inhibitor was mediated by the proteasome, we cultured and Supporting Information Figure S2 ). The immunostaining
experiment indicates that the interaction between Pin1 and Smad3 occurs more in the cytosol ( Figure S3 ).
Similar to previous studies, we also found a reduced fusion index in C2C12 cells overexpressing Smad3; however, 48 hr after differentiation, the DTM treatment for an additional 48 hr reversed this and caused myotube formation (Figure 3f ), as indicated by the fusion index (Figure 3g ). These data demonstrate that 
| Expression of muscle atrophy-related genes downstream of Smad3 regulated by Pin1
We deduced from our data that Pin1 modulates Smad3 expression.
Smad3 also regulates muscle bulk by altering the expression of atrogenes (muscle atrophy-related genes; Bollinger, Witczak, Houmard, & Brault, 2014; Goodman, McNally, Hoffmann, & Hornberger, 2013) . For instance, Smad3 is needed to upregulate the E3-ubiquitin ligase F-box only protein 32 (also known as atrogin-1, Fbxo32, and MAFbx), a well-known skeletal muscle atrogene (Trendelenburg et al., 2009; Waning et al., 2015; Welle, 2009 ). Atrogin-1 and Trim63 (MuRF1) are upregulated during muscle atrophy and tend to degrade myofibrillar elements, MyoD, and components of the muscle hypertrophy pathway and translational machinery (Lecker et al., 2004) .
We found that both atrogin-1 and Murf-1 mRNA levels were reduced when Pin1 was inhibited in vitro, even in the presence of TGF-β (Figure 5a ). Murf-1 (Figure 5b ) and Maf ( Figure S4) expressions were also reduced in the Pin1 +/− tibialis anterior muscle.
Atrogin-1 was detected in Pin1 +/+ samples but was undetectable in Pin1 +/− samples (Figure 5b ). Musa-1, a newly identified denervation atrophy-related gene (Sartori et al., 2013) , was upregulated in Pin1 +/− samples ( Figure S4 ), probably due to the downregulation of Smad1/5 resulting from the reduced Pin1 level (Yoon et al., 2015) . These observations indicate that Pin1 regulates atrogenes that are downstream of Smad3 and suggest that the inhibition of Pin1 and subsequent degradation of Smad3 promote hypertrophy not only in terms of the number of nuclei but also in terms of the total muscle fiber content.
Indeed, we confirmed that Pin1 +/− muscle had more fibers with larger CSAs than Pin1 +/+ muscle (Figure 1 ). F I G U R E 3 Smad3 level in muscle is regulated by peptidyl-prolyl cis-trans isomerase NIMA interacting 1 (Pin1). (a) Phosphorylated Smad 3 was reduced with low-dose dipentamethylene thiuram monosulfide (DTM) (0.01 μM) treatment in the fusion medium. Western blot analysis was done to observe C-terminal tail-phosphorylated R-Smad protein (pSmad3, pSmad2, and pSmad1) levels in the C2C12 cell treated with DTM (0.01 μM) for 24 hr in fusogenic media. β-Actin was used as loading control. The average pSmad3 band intensity after normalization is shown below the band inside the figure. Statistics of the densitometry data was calculated using GraphPad Prism software. p< In addition to the C-tail, three (S/T)-P sites in the Smad3 linker region-Ser208, Ser204, and Thr179-are phosphorylated in response to TGF-β (Kamato et al., 2013) . Linker phosphorylation peaks 1 hr after TGF-β treatment, following the peak of C-tail phosphorylation (Wang, Matsuura, He, & Liu, 2009 ). Previously, ITC titrations revealed that the affinity of the Pin1 WW domain was twice as great for pT179 within a Smad3 176-193 peptide (Kilodalton; kDa = 12.6 ± 1 μM) than for pS204/pS208 within a Smad3 202-211 peptide (kDa= 23.4 ± 7 μM) and that Pin1 did not bind to S213 in the Smad3 linker region (Aragon et al., 2011) . We found that Pin1 bound more strongly to S204 and S208 in the Smad linker region than to T179 after 1 hr of TGF-β stimulation in C2C12 cells (Figure 6a ).
| Binding of Pin1 to S204 might have a role in myoblast fusion
To determine whether these residues were involved in myoblast fusion and differentiation, we transiently transfected C2C12 cells with formation of many elongated cells containing two nuclei (Figure 6b) . Thus, S204 in the Smad3 linker region might have a specific role in myoblast fusion and is a Pin1-binding site after TGF-β signal activation in myoblasts. We also found that cells overexpressing Smad3 with all of its linker sites mutated (with intact C-terminal phosphorylation) also showed formation of multinucleated myotubes (Supporting Information Figure S5 ).
| ERK-mediated phosphorylation is required for the binding of Pin1 to Smad3 after TGF-β stimulation in myoblasts
During or directly prior to the assembly of Smad proteins into transcriptional complexes, linker phosphorylation is mediated by cytoplasmic MAPK or by CDK8 and CDK9 .
However, in muscle cells that are old or have been treated with TGF-β, CDK inhibitors are expressed (Carlson et al., 2008) . We measured the expression of the CDK inhibitor CDKN1A in postmitotic C2C12 cells and found that TGF-β increased its transcript level (Supporting Information Figure S7 ).
We found that with Pin1 overexpression the interaction between total Smad3 and GSK3α/β is reduced (Supporting Information Figure S2 ).
A candidate for S204 phosphorylation is GSK3β (Aragon et al., 2011) , but it is known that only nonactive Smad3 physically interacts with GSK3β (Guo et al., 2008) . 
| DISCUSSION
Although associated with viral infections and neoplasia, spontaneous cell-cell fusion, or syncytialization, is a key part of normal development in tissues such as muscle (Abmayr & Pavlath, 2012) and bone (Soe et al., 2011) and is crucial for their proper functioning.
Myoblast fusion is a critical aspect of muscle differentiation, and the control of fusion might occur through different pathways.
Pin1 is an important and ubiquitous protein that maintains the balance of many biological processes (Liou et al., 2002) . The elevation of Pin1 in cancer cells suggests that this protein regulates cellular growth and proliferation (Bao et al., 2004) .
Unlike transformed proliferative cells, mature myotubes are postmitotic, highlighting the context-dependent nature of Pin1 function. Our findings support a role for Pin1 as a regulator of skeletal muscle fusion at both the cellular and organ levels (Figures 1,2) . The small increase in the myogenin transcript level only on the third day after treatment with the Pin1 inhibitor DTM during differentiation (Supporting Information Figure 2 ) suggests that Pin1 inhibition does not stimulate all steps of differentiation and that, during myoblast fusion, Pin1 might also have a role independent of the differentiation process. Although Smad3 was identified as a target of the Pin1-mediated inhibition of muscle fusion, it might not be the only one, as the Pin1 inhibitor treatment after Smad3 overexpression further enhanced the fusion index even after restoring it to a normal level (Figure 3 ).
Thus, other substrates might be regulated by Pin1 during muscle fusion. From our observation, we believe that Smad3 is one of the most important candidates in the regulation of myoblast fusion by Pin1.
The conditions that induce muscle atrophy also activate the myostatin-TGF-β pathway. Myostatin and other TGF-β family members bind activin type II receptors, resulting in Smad2/3 phosphorylation and a reduction in muscle mass (Egerman & Glass, 2014; McFarlane et al., 2006; Ruegg & Glass, 2011) . Thus, inhibition of TGF-β improves muscle strength (Waning et al., 2015) . With age, there is a dramatic and constant upregulation of TGF-β (inactive precursor plus bioactive protein) and pSmad3 (Carlson et al., 2008) . Smad3 is a critical regulator of overall muscle bulk. Smad3 knockout mice exhibit atrophy (Ge et al., 2011) , whereas Smad3 inhibition increases muscle bulk (Burks & Cohn, 2011; Sartori et al., 2009 ). The Smad3 knockout phenotype is similar to the phenotypes seen in Pin1 −/− mice. The Pin1 +/− mice in which Smad3 is functionally inhibited may mimic models of Smad3 inhibition. In the case of Smad3, this paradox is sometimes attributed to an increase in availability of Smad4 to the BMP pathway when Smad3 is inhibited (Sartori et al., 2013) . As Pin1 targets Smad3, it might explain why inhibition of Pin1 at low doses shows more fusion. Analysis of the distribution of muscle fiber CSA demonstrated that Pin1 +/− muscle had not only a higher nuclear content but also larger myofibrils (Figure 1 ).
Although Pin1 +/− muscle cross-sections exhibited rounded hypertrophic fibers, they did not display signs of myopathy such as angulated atrophic myofibers, fiber-type grouping, group atrophy, target fibers, nuclear clumps, myofiber necrosis, myophagocytosis, regenerating fibers, myofiber splitting, increases in centrally positioned or internal nuclei, or nuclear inclusions in histology.
| ISLAM ET AL.
F I G U R E 7 Smad3 requires ERK-mediated phosphorylation at S204 to bind peptidyl-prolyl cis-trans isomerase NIMA interacting 1 (Pin1). Binding of Pin1 to Smad3 has different consequences in different contexts and cell types, such as promoting TGF-β signaling without changing the protein level of Smad3 (Matsuura et al., 2010) or inducing the degradation of Smad3 (Nakano et al., 2009 ). It was suggested in an earlier report that the conformational status and final consequences of R-Smad can vary according to the physiological or pathological setting (Wrighton et al., 2009) . Pin1 is also known to be required for the TGF-β-induced phosphorylation, nuclear translocation, and transcriptional activity of Smad3 (Yang et al., 2014) .
Externalization of Pin1 into the cytosol (Magli et al., 2010a ) might be an important part of the myogenic program in which Pin1 binds to the master regulator Smad3, mediates its conformational change in the cytosol, and governs the consequences of BMP-TGF signaling.
Pin1 interacts with Smad2/3 in a TGF-β1-dependent manner, and
Pin1 is actively involved in the TGF-β1-stimulated migration and invasion of PC3 prostate cancer cells (Matsuura et al., 2010) . Both
Smad-dependent gene transcription and Smad2/3 phosphorylation were found to be lower in Pin1 −/− MEFs than in Pin1 +/+ MEFs (Yang et al., 2014) . According to previous reports, CDK8/9-mediated phosphorylation of pSmad3 creates binding sites for Pin1, resulting in transcriptional activation of pSmad3 (Aragon et al., 2011; Gao et al., 2009) . From our experimental data, it can be inferred that Pin1
is biologically important for maintaining the balance in Smad signaling during fusion (Figures 5,6 ) to regulate muscle bulk and that ERK-mediated phosphorylation is required for the interaction between Pin1 and Smad3 after TGF-β activation (Figure 7 ).
We demonstrated that Pin1 modulates the muscle fiber size by stabilizing Smad3 while simultaneously upregulating the expression of growth-limiting genes such as Atrogin-1 and Trim63 (MuRF1).
The increase in Musa-1 might have been due to the downregulation of Smad1/5 resulting from the decrease in the Pin1 protein Yoon et al., 2015) . A major limitation in our understanding of TGF-β biology is the lack of knowledge as for a direct link between TGF-β "Smad signaling" and "non-Smad" Cancer-related muscle atrophy (cachexia), which is characterized by the progressive loss of skeletal muscle mass, affects up to 80% of patients with advanced cancer (Tisdale, 2002) and is estimated to be responsible for~25% of the deaths in these patients (Tse, 2010) .
Recently, Smad3 was also implicated as a major player in cancer cachexia (Waning et al., 2015) . Therapeutic strategies to prevent muscle wastage are limited, and the underlying mechanisms are unclear. Discovering the mechanism of Pin1 inhibition-based muscle fusion could facilitate the discovery of drug targets for the same purpose.
The excessive inhibition or total absence of Pin1 might have adverse effects, such as neurodegeneration or osteoporosis (Islam et al., 2014; Shin et al., 2016) . However, in our study, only a low dose of the Pin1 inhibitor enhanced muscle fusion. Tight control of the fusion process through Pin1 might be a natural strategy to prevent the fusion of inappropriate cell types and the formation of abnormal, 
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SUMMARY STATEMENT
Myoblast fusion is pivotal for muscle development. We found that postphosphorylation isomerization of Smad3 by Pin1 is a crucial mechanism that governs myoblast fusion and maintains muscle mass. 
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